MARKET

LFCR

LFCR

Lifecore Biomedical Inc
NASDAQ
5.83
-0.13
-2.18%
Closed 16:00 05/22 EDT
OPEN
5.81
PREV CLOSE
5.96
HIGH
5.96
LOW
5.81
VOLUME
212.86K
TURNOVER
0
52 WEEK HIGH
11.46
52 WEEK LOW
4.500
MARKET CAP
178.09M
P/E (TTM)
-1.7542
1D
5D
1M
3M
1Y
5Y
LIFECORE BIOMEDICAL INC - ON MAY 20 PAUL JOSEPHS BEGAN SERVING AS CO'S PRESIDENT AND CHIEF EXECUTIVE OFFICER
Reuters · 43m ago
*22NW Fund Also Planned to Nominate Two Class I Directors, But Lifecore Said Only Class II Directors Would Be Up for Election at Aug. Meeting
Dow Jones · 2d ago
*22NW Fund Nominates Nathaniel Calloway, Matthew Korenberg, Elaine Thibodeau and Beau Garrett as Class II Directors
Dow Jones · 2d ago
*22NW Fund Submits Lifecore Biomedical Board Nominations
Dow Jones · 2d ago
Weekly Report: what happened at LFCR last week (0513-0517)?
Weekly Report · 2d ago
Lifecore Biomedical Asset Transfer for Creditor Settlement
TipRanks · 6d ago
Lifecore Biomedical Completes Incremental Liquidity Initiatives
Lifecore Biomedical, Inc. Announced certain incremental liquidity measures and housekeeping matters related to divested businesses over the past week. The company is a fully integrated contract development and manufacturing organization. Lifecore is headquartered in Minneapolis, Minnesota.  
Barchart · 6d ago
Weekly Report: what happened at LFCR last week (0506-0510)?
Weekly Report · 05/13 09:18
More
About LFCR
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Webull offers Lifecore Biomedical Inc stock information, including NASDAQ: LFCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LFCR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LFCR stock methods without spending real money on the virtual paper trading platform.